Merck has appended a short survey to its MerckEngage.com education and awareness website in an effort to predict patients' risk of failing to adhere to a newly prescribed drug regimen. "Our studies point specifically to three health beliefs that are the best predictors: understanding why the medicine is needed and being committed to its use, concern about taking the medicine, and perceived cost issues," said Dr. Sethu Reddy, Merck's U.S. vice president for medical affairs. The company will attempt to address the concerns of patients deemed at risk for non-adherence.

Related Summaries